Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19

NCT04513561 · clinicaltrials.gov ↗
COMPLETED
Status
921
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University Hospital, Lille